2-chloro-2'-deoxyadenosine in the treatment of Sjögren's syndrome-associated B cell lymphoproliferation

Arthritis Rheum. 2002 Aug;46(8):2248-9. doi: 10.1002/art.10434.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / therapeutic use*
  • B-Lymphocytes / pathology*
  • Cladribine / administration & dosage
  • Cladribine / therapeutic use*
  • Female
  • Humans
  • Infusions, Intravenous
  • Lymphoma / complications
  • Lymphoma / drug therapy*
  • Lymphoma / pathology
  • Male
  • Middle Aged
  • Sjogren's Syndrome / complications
  • Sjogren's Syndrome / drug therapy*
  • Sjogren's Syndrome / pathology
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Cladribine